Inactive Instrument
Eurofins-Cerep Stock Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 87.26M 101M 80.44M 75.37M 141M 9.63B 144M 960M 371M 4.64B 377M 369M 16.14B | P/E Ratio 2024 * |
-
| P/E Ratio 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 66.23M 76.32M 61.05M 57.2M 107M 7.31B 109M 728M 282M 3.52B 286M 280M 12.25B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 2024-04-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 2023-08-10 |
Damien Vielliard
BRD | Director/Board Member | - | 2024-05-22 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +4,900.50% | - | - | 101M | |
| -0.55% | +0.82% | -16.08% | -12.85% | 42.96B | |
| +3.27% | +3.41% | +275.38% | +509.72% | 31.73B | |
| -0.60% | -1.67% | +13.36% | -14.87% | 30.22B | |
| +1.97% | -1.36% | -3.65% | +24.97% | 28.94B | |
| +4.09% | -1.98% | +11.99% | +17.37% | 23.87B | |
| -1.05% | +3.89% | +55.23% | +116.45% | 13.57B | |
| -0.40% | -1.29% | +6.06% | +7.59% | 12.96B | |
| +3.02% | +6.20% | - | - | 13.39B | |
| -1.52% | -1.52% | +105.92% | +76.20% | 12.2B | |
| Average | +0.86% | -0.71% | +56.03% | +90.57% | 23.31B | |
| Weighted average by Cap. | +1.08% | -1.08% | +54.73% | +96.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.66M 37.32M 34.97M 65.34M 4.47B 66.7M 445M 172M 2.15B 175M 171M 7.49B | 41.1M 47.36M 37.88M 35.5M 66.32M 4.53B 67.71M 452M 175M 2.19B 178M 174M 7.6B |
| Net income | 7.15M 8.24M 6.59M 6.18M 11.55M 789M 11.79M 78.67M 30.46M 381M 30.95M 30.28M 1.32B | 4.78M 5.51M 4.41M 4.13M 7.72M 528M 7.88M 52.59M 20.36M 254M 20.69M 20.24M 884M |
| Net Debt | -17.25M -19.88M -15.9M -14.9M -27.84M -1.9B -28.42M -190M -73.45M -918M -74.63M -73.03M -3.19B | -21.03M -24.24M -19.39M -18.17M -33.95M -2.32B -34.65M -231M -89.55M -1.12B -90.99M -89.03M -3.89B |
Employees
-
